df2755a
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 15, 2018 (NCT04803396)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Chemokine XC receptor 1INHIBITOR
XCR1 inhibitor
- Interleukin-8 receptor BINHIBITOR
CXCR2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04803396 | Phase 1 | Nov 15, 2018 | Dompe Pharmaceuticals, Eurofins |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dompe Pharmaceuticals | For profit | 1 | 1 | 1 | 2018 |
| Eurofins | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1